Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid for Osteoporosis Prevention in HCT
NCT00321932Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Jul 2005
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronic acid in osteoporosis, sponsored by University of Minnesota. Started Jul 2005; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00321932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00321932.